News

 A new core laboratory at the University of Kansas will enhance the speed, quantity and quality of research into infectious diseases, neurological disorders, cancer and immunology.

Joanna Slusky, Associate Professor in the Department of Molecular Biosciences at the University of Kansas, received a four-year grant from the National Institute of General Medical Sciences with a total cost of $1,244,968.

Research from the University of Kansas just published in Proceedings of the National Academy of Sciences could hasten development of a new class of vaccines aimed at SARS-CoV-2, the virus that causes COVID-19.

Congratulations to Dr. Anthony Fehr, Molecular Biosciences, for his most recent publication.

Congratulations to Dr. Anthony Fehr, Molecular Biosciences, on his promotion to Associate Professor with tenure.  As a CBID faculty recruit and program graduate, we are excited to celebrate your promotion.

Examples of infections tied to gram-negative bacteria include pneumonia, bloodstream infections, wound-site infections and meningitis, according to the Centers for Disease Control and Prevention.

Dr. Joanna Slusky, CBID Pilot Project Awardee, has been granted an R01 award by the National Institutes of Health.  This three year award totals $311,242 and is titled "Plugging & Pulling-in: tuning peptides for ToIC to overcome antibiotic resistance".

Dr. Joanna Slusky, Molecular Biosciences, had an article published in PNAS today.

Dr. Anthony Fehr, Assistant Professor of Molecular Biosciences, was awarded $50,000 by the University of Kansas Medical Center Research Institute for his project "Investigating Approved Therapeutics For Their Ability To Inhibit the SARS-CoV-2 ADPribosylhydrolase: 2022-2023."

Dr. Mark Farrell, Assistant Professor of Medicinal Chemistry, was granted a National Institutes of Health award for $1,912,500.  Titled "Glycoscience Tools and Therapeutics, this five year award is part of the R35 program known as the Outstanding Investigator Award.